Transformation Capital is a growth equity fund 100% focused on innovative healthcare IT and services companies.
Business Model: B2B
Revenue: $0
Employees: 0-0
Address: 1 Federal Street
City: Boston
State: MA
Zip: 02110
Country: US
Transformation Capital is the successor management company to Leerink Transformation Partners LLC (“LTP”).11 LTP was founded in 2016 by Todd Cozzens and Jared Kesselheim, MD together with SVB Leerink Capital LLC (formerly Leerink Capital Partners LLC) (“Leerink Capital”), an affiliate of SVB Leerink LLC (“Leerink”), a leading healthcare investment bank. Leerink Capital provided seed capital to Fund I (approximately 3% of capital commitments) and operational support. In January of 2019, SVB Financial Group (“SVB”), the holding company of Silicon Valley Bank, a U.S.-based high-tech commercial bank, acquired the Leerink businesses including Leerink Capital. Todd Cozzens, Jared Kesselheim, MD and SVB expect to agree to a mutually beneficial ongoing relationship in which Transformation Capital (as an independent management company owned by Todd Cozzens, Jared Kesselheim, MD and Michael Dixon and not affiliated with SVB or Leerink Capital) shall manage Fund II and whereby Transformation Capital shall manage Fund I’s investment portfolio pursuant to a sub-advisory agreement with SVB (or an affiliate). Transformation Capital has the same operational leader, Kevin Brown, formerly CFO of Leerink Capital, and Transformation Capital expects to continue to derive benefits from its ongoing relationship with Leerink and SVB.
Contact Phone:
Contact Email:
Announced Date | Company | Transaction | Money Raised |
---|---|---|---|
8/2022 | Plume | Series B | 24M |
7/2022 | Tebra | Series B | 0 |
3/2022 | Nayya | Series C | 0 |
9/2022 | LetsGetChecked | Series D | 0 |
5/2020 | LetsGetChecked | Series C | 71M |
11/2021 | Sword Health | Series D | 0 |
6/2020 | PatientPing | Series C | 0 |
1/2020 | PatientPoint | Venture Round | - |
10/2020 | Datavant | Series B | 40M |
9/2022 | Grow Therapy | Series B | 45M |
8/2022 | Annexus Health | Series B | 0 |
9/2021 | Vital | Series A | 15M |
4/2023 | Memora Health | Venture Round | 0 |
8/2020 | PatientPop | Series C | 50M |
12/2020 | H1.co | Series B | 58M |
11/2021 | H1.co | Series C | 0 |
6/2021 | LetsGetChecked | Series D | 150M |
1/2020 | Groups Recover Together | Venture Round | - |
12/2019 | Scientist.com | Funding Round | 7.4M |
1/2021 | Sword Health | Series B | 0 |
3/2023 | Vital | Series B | 0 |
6/2023 | DexCare | Series C | 0 |
6/2022 | Capital Rx | Series C | 0 |
2/2022 | Memora Health | Venture Round | 0 |
3/2021 | Ginger | Series E | 100M |
1/2022 | DexCare | Series B | 0 |
6/2020 | RapidSOS | Venture Round | 0 |
6/2019 | Health Catalyst | Venture Round | - |
4/2021 | CareRev | Series A | 50M |
3/2021 | Cleo | Series C | 40M |
6/2021 | Protenus | Series D | 0 |
7/2021 | Thriveworks | Venture Round | - |
6/2020 | Kyruus | Venture Round | 30M |
2/2021 | Capital Rx | Series B | 50M |
5/2019 | Panalgo | Private Equity Round | 78M |
3/2022 | Jeenie | Series A | 0 |
9/2020 | Aktana | Series D | - |
7/2021 | TMRW Life Sciences | Series C | 105M |
6/2021 | Sword Health | Series C | 0 |
3/2021 | Unite Us | Series C | 150M |
6/2022 | H1.co | Series C | 0 |
5/2021 | Groups Recover Together | Series C | 60M |
12/2020 | Olive | Series G | 225.5M |
4/2020 | Vera Whole Health | Venture Round | 10M |
6/2020 | PlushCare | Series B | 23M |
8/2022 | Annexus Health | Series B | 0 |
7/2022 | Tebra | Series B | 0 |
6/2022 | Capital Rx | Series C | 0 |
6/2022 | H1.co | Series C | 0 |
3/2022 | Jeenie | Series A | 0 |
3/2022 | Nayya | Series C | 0 |
2/2022 | Memora Health | Venture Round | 0 |
1/2022 | DexCare | Series B | 0 |
11/2021 | Sword Health | Series D | 0 |
11/2021 | H1.co | Series C | 0 |
Name | Price |
---|
Name | Size | Announced Date |
---|